Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

M2e-based universal influenza vaccines: a historical overview and new approaches to development
Daria Mezhenskaya, Irina Isakova–Sivak, Larisa Rudenko
Journal of Biomedical Science (2019) Vol. 26, Iss. 1
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Influenza and Universal Vaccine Research in China
Jiali Li, Yifan Zhang, Xinglong Zhang, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 116-116
Open Access | Times Cited: 40
Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines
Caryn Myn Li Lim, Thamil Vaani Komarasamy, Nur Amelia Azreen Adnan, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 14
Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice
Ling Huang, Wei Tang, Lina He, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Controlled Human Infection Models To Accelerate Vaccine Development
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 26
Displaying and delivering viral membrane antigens via WW domain–activated extracellular vesicles
Sengjin Choi, Zhiping Yang, Qiyu Wang, et al.
Science Advances (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 16
Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus
Hai Xu, Shanyuan Zhu, Roshini Govinden, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1694-1694
Open Access | Times Cited: 14
Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice
Jiaojiao Nie, Yong-Fei Zhou, Fan Ding, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129259-129259
Closed Access | Times Cited: 5
In situ bio-mineralized Mn nanoadjuvant enhances anti-influenza immunity of recombinant virus-like particle vaccines
Yanan Sheng, Zhengjun Li, Xuan Lin, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 275-289
Closed Access | Times Cited: 5
Progress in the Development of Universal Influenza Vaccines
Wenqiang Sun, Tingrong Luo, Wenjun Liu, et al.
Viruses (2020) Vol. 12, Iss. 9, pp. 1033-1033
Open Access | Times Cited: 36
Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses
Lucas Kerstetter, Stephen Buckley, Carly M. Bliss, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 32
Self-assembled peptide nanorod vaccine confers protection against influenza A virus
Ximena Zottig, Al Halifa Soultan, Mélanie Côté‐Cyr, et al.
Biomaterials (2021) Vol. 269, pp. 120672-120672
Closed Access | Times Cited: 31
Influenza vaccine: progress in a vaccine that elicits a broad immune response
Irina Isakova–Sivak, Ekaterina Stepanova, Daria Mezhenskaya, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 9, pp. 1097-1112
Closed Access | Times Cited: 30
Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
Mengling Li, Pengju Guo, Cen Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection
Feng Xu, Ye Yuan, Ying Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114117-114117
Open Access | Times Cited: 22
An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets
Jae-Keun Park, Sharon L. Fong Legaspi, Louis M. Schwartzman, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 653
Open Access | Times Cited: 19
Single-Component Multilayered Self-Assembling Protein Nanoparticles Displaying Extracellular Domains of Matrix Protein 2 as a Pan-influenza A Vaccine
Keegan Braz Gomes, Yi-Nan Zhang, Yi-Zong Lee, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23545-23567
Open Access | Times Cited: 12
Next-Generation Influenza Vaccines
Masaru Kanekiyo, Barney S. Graham
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 8, pp. a038448-a038448
Open Access | Times Cited: 30
Animal Models Utilized for the Development of Influenza Virus Vaccines
Ericka Kirkpatrick Roubidoux, Stacey Schultz‐Cherry
Vaccines (2021) Vol. 9, Iss. 7, pp. 787-787
Open Access | Times Cited: 25
Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development
Yiwen Zhao, Zhuofan Li, Jewel Voyer, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 19, pp. 21872-21885
Open Access | Times Cited: 17
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines
Sean A. Nelson, Katherine A. Richards, Maryah A. Glover, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 17
Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles
Keegan Braz Gomes, Sharon Vijayanand, Priyal Bagwe, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10612-10612
Open Access | Times Cited: 10
Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines
Alexandra Rak, Irina Isakova–Sivak, Larisa Rudenko
Vaccines (2023) Vol. 11, Iss. 12, pp. 1747-1747
Open Access | Times Cited: 10
Conformation and Membrane Topology of the N-Terminal Ectodomain of Influenza A M2 Protein
Kyra C. Roeke, Kathleen P. Howard
Membranes (2025) Vol. 15, Iss. 2, pp. 40-40
Open Access
A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector
Yixin Niu, Yao Yan, Ying Hu, et al.
Vaccine (2025) Vol. 53, pp. 126959-126959
Closed Access
Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses
Qimin Wang, Yuling Zhang, Peng Zou, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top